CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP Trial Mechanical circulatory support devices for acute right ventricular failure SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Modifiable lifestyle factors and heart failure: A Mendelian randomization study

Clinical Trial15 Nov 2021

JOURNAL:Circulation. Article Link

Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

J Butler, G Filippatos, TJ Siddiqi et al. Keywords: HFpEF; empagliflozin; health status

Full Text PDF